Oncotarget Archives | Oncotarget

Oncotarget News

Oncotarget | Targeted Elastin-like Polypeptide Fusion Protein for Near-infrared Imaging of Human and Canine Urothelial Carcinoma

September 8, 2022

We have developed a peptide-based NIR probe, Cy5.5-N24-EGF, that shows high EGFR-specific binding specificity in canine and human UC in vitro and ex vivo.”BUFFALO, NY- September 8, 2022 –... read more

Figure 2: TMB distribution in non-small cell lung cancer

Oncotarget

Mutational Burden in Lung Cancer Studied in Multisite Cohort

April 25, 2022

BUFFALO, NY-April 25, 2022 – A new research paper, entitled, “Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study,” was published in Oncotarget... read more

Dr. Stanley Lipkowitz and Dr. Yoshimi Endo Greer

Oncotarget

Behind the Study: How ONC201 Kills Breast Cancer Cells

April 22, 2022

Dr. Stanley Lipkowitz and Dr. Yoshimi Endo Greer from the Women’s Malignancies Branch at the National Cancer Institute discuss a research paper they co-authored that was published by Oncotarget... read more

Oncotarget

Impact Journals at AACR Annual Meeting 2022

March 28, 2022

BUFFALO, NY-March 28, 2022 – Impact Journals publishes scholarly journals in biomedical sciences with a focus on all areas of cancer and aging research. Impact Journals will... read more

Oncotarget

Behind the Study: Targeting Stem Cells in Non-Small Cell Lung Cancer

March 25, 2022

Dr. Beatrice Aramini and Dr. Valentina Masciale from the University of Modena and Reggio Emilia details a 2020 research paper she co-authored and published by Oncotarget, entitled, “CD44+/EPCAM+... read more

Oncotarget

Oncotarget’s Top 10 Most-Viewed Papers in 2021

January 21, 2022

Read the 10 most-viewed oncology-focussed papers on Oncotarget.com in 2021.—#10: Metformin and berberine, two versatile drugs in treatment of common metabolic diseasesAuthors: Haoran Wang, Chen... read more

Oncotarget

Open-Access Oncotarget Shifts to Continuous Publishing

January 6, 2022

As of 2022, the peer-reviewed and open-access journal Oncotarget has shifted to continuous publishing.—BUFFALO, NY, January 6, 2022 – Since its inception in 2010, Oncotarget ... read more

Oncotarget

Captain of Team Open Access Rides Again for Cancer Research

August 16, 2021

For the past four summers, Impact Journals has sponsored Team Open Access in the Ride for Roswell. The peloton has been captained by Sergei Kurenov, who is the... read more

Oncotarget

Oncotarget Podcast Episodes: The Latest in Oncology-Focused Research

February 24, 2021

Hundreds of scientific studies, reviews, and analyses are being published from around the world at any given time. This can make reading the latest research literature a time consuming task—... read more

Oncotarget

Behind the Study: Statins Primary Mode of Action Against Cancer Cells

February 15, 2021

Neuro-oncologist physician-scientist Dr. Benjamin Purow describes the findings in a paper he helped author in Oncotarget titled, "Statins affect human glioblastoma and other cancers through TGF-β inhibition."The Behind... read more